These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 18059320)

  • 1. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
    Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors: signalling towards p21cip1/waf1.
    Ocker M; Schneider-Stock R
    Int J Biochem Cell Biol; 2007; 39(7-8):1367-74. PubMed ID: 17412634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
    Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.
    Roy Choudhury S; Karmakar S; Banik NL; Ray SK
    Invest New Drugs; 2010 Dec; 28(6):812-24. PubMed ID: 19777160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
    Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
    Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
    Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.
    Mühlethaler-Mottet A; Meier R; Flahaut M; Bourloud KB; Nardou K; Joseph JM; Gross N
    Mol Cancer; 2008 Jun; 7():55. PubMed ID: 18549473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.
    Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J
    Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
    Fortson WS; Kayarthodi S; Fujimura Y; Xu H; Matthews R; Grizzle WE; Rao VN; Bhat GK; Reddy ES
    Int J Oncol; 2011 Jul; 39(1):111-9. PubMed ID: 21519790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
    Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
    Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
    J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.
    Langley B; D'Annibale MA; Suh K; Ayoub I; Tolhurst A; Bastan B; Yang L; Ko B; Fisher M; Cho S; Beal MF; Ratan RR
    J Neurosci; 2008 Jan; 28(1):163-76. PubMed ID: 18171934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.
    Torres J; Regan PL; Edo R; Leonhardt P; Jeng EI; Rappaport EF; Ikegaki N; Tang XX
    Int J Oncol; 2010 Oct; 37(4):983-91. PubMed ID: 20811720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histone deacetylase inhibitors cause the TP53-dependent induction of p21/Waf1 in tumor cells carrying mutations in TP53].
    Kovalev RA; Shtam TA; Karelov DV; Burdakov VS; Volnitskiy AV; Makarov EM; Filatov MV
    Tsitologiia; 2015; 57(3):204-11. PubMed ID: 26021170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.
    Fortunati N; Bertino S; Costantino L; Bosco O; Vercellinatto I; Catalano MG; Boccuzzi G
    Cancer Lett; 2008 Feb; 259(2):156-64. PubMed ID: 18006146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.
    Brochier C; Dennis G; Rivieccio MA; McLaughlin K; Coppola G; Ratan RR; Langley B
    J Neurosci; 2013 May; 33(20):8621-32. PubMed ID: 23678107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.